பரவுகிறது வெட்டு முறையான ஸ்க்லரோசிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பரவுகிறது வெட்டு முறையான ஸ்க்லரோசிஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பரவுகிறது வெட்டு முறையான ஸ்க்லரோசிஸ் Today - Breaking & Trending Today

Lenabasum Missed Primary Endpoint for dcSSc but Isn't Dead Yet

Lenabasum Missed Primary Endpoint for dcSSc but Isn't Dead Yet
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Hospital For Special Surgery , Robert Spiera , Eli Lilly , Van Laar , Bristol Myers Squibb , European Congress , Boehringer Ingelheim , Health Assessment Questionnaire Disability Index , Scleroderma Program , European Alliance Of Associations , University Medical Center Utrecht , Leiden University Medical Center , Special Surgery , New York City , Medscape Medical , Immunosuppressants Contribute , Unprecedented Placebo , Combined Response Index , Diffuse Cutaneous Systemic Sclerosis , Secondary Endpoints Followed Same Pattern , Formation Biologics , Arxx Therapeutics , Merck Sharp , புதியது யார்க் ,

Corbus Pharmaceuticals Announces Publication of Two

Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress
Corbus Pharmaceuticals Holdings, Inc.
Norwood, Massachusetts, UNITED STATES
Norwood, MA, May 25, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2021 Virtual Congress that will be taking place June 2-5, 2021.
Details of the presentations are as follows:
Presentation Title
: Phase 3 Trial of Lenabasum, a CB2 Agonist, for the Treatment of Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Session: Progress in myositis and scleroderma research - I ....

Lindsey Smith , Ted Jenkins , Robert Spiera , University Of Pennsylvania Perelman School Medicine , Corbus Pharmaceuticals Holdings Inc , Weill Cornell Medical College , Peuropean League Against Rheumatism , Exchange Commission , Corbus Pharmaceuticals Contacts , Corporate Communications , Securities Exchange , Virtual Congress , Myositis Program , Pharmaceuticals Holdings , Diffuse Cutaneous Systemic Sclerosis , Special Surgery , Co Principal Investigator , Corbu Phase , Long Term Safety , Open Label Extension , Refractory Skin Disease , Victoria Werth , Pennsylvania Perelman School , Scientific Conferences , Securities Act , Securities Exchange Act ,